Person profile

Public information reviewed

Erez Aminov

Role

Chief Executive Officer and Chairman at Telomir Pharmaceuticals, Inc. (NASDAQ: TELO)

Board role

Director · MIRA PHARMACEUTICALS, INC. (NASDAQ: MIRA)

Board role

Chief Executive Officer and Chairman · Telomir Pharmaceuticals, Inc. (NASDAQ: TELO)

Telomir Pharmaceuticals, Inc. (NASDAQ: TELO)

Chief Executive Officer and Chairman · Current mandate

Director · Executive
FollowSave PDF
More
Reports & analysisAlpha Eval
Public sources
7 reviewed
Profile ownership
Not yet claimed
Last reviewed
Sep 13, 2026
View sources

Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
32 current organizations shown on this profile
Board positions
22 supported by public sources, 0 supplied by the profile owner
Committee roles
1Roles supported by the sources cited on this profile
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Experienced biotechnology consultant and investor with over two decades in the biotech industry. Founded Locate Venture Corp., a strategy and investment consulting firm focused on early-stage biotech startups, and previously served as President of Finds4less Inc.

Sources are shown with the information they support.

Current roles

Appointments & responsibilities

Executive appointments

Board appointments

Governance

Board appointments, committee responsibilities and disclosed relationships.

Board and advisory record

Board service

Sources are shown with each role, education record, or credential.

Director

MIRA PHARMACEUTICALS, INC.

2023-01-01 · current

Confirmed by public sourceView source

Chief Executive Officer and Chairman

Telomir Pharmaceuticals, Inc.

Current · start date not disclosed

Confirmed by public sourceView source

Connections

Explore the roles, education and affiliations published in this record.

MIRA PHARMACEUTICALS, INC.

Open MIRA PHARMACEUTICALS, INC. profile →

Director at MIRA PHARMACEUTICALS, INC.

2023-01-01 → End not stated

current · source reported

Observed: 2026-09-18

MIRA PHARMACEUTICA…MIRA PHARMACEUTICALS, INC.Telomir Pharmaceut…Telomir Pharmaceuticals, Inc.Erez Aminov

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec Def 14aPublic profile sourceSupports Chief Executive Officer and Chairman at Telomir Pharmaceuticals, Inc. (NASDAQ: TELO).Open sourceSource 2 · Sec FilingMIRA 10-K executive officersSupports Executive company, Executive title, Other Company Role.Open sourceSource 3 · Sec FilingTELO 10-K executive officersSupports AI and ML experience, Cybersecurity experience, Executive company, Executive title, Technology background.Open sourceSource 4 · Sec FilingMIRA DEF 14A director slateSupports AI and ML experience, Board role, Committee assignments, Executive company, Executive title, Cybersecurity experience, Technology background.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:erez-aminov
Record version
public-0

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · CorroboratedAI and ML experience: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Board membership · Source reportedServes on the board of MIRA PHARMACEUTICALS, INC.1 source
Verification
Source reported
Confidence
Not stated
Last reviewed
Not stated
Board membership · Source reportedServes on the board of Telomir Pharmaceuticals, Inc.1 source
Verification
Source reported
Confidence
Not stated
Last reviewed
Not stated
Board role · Source reportedBoard role: Chair1 source
Verification
Source reported
Confidence
92%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Committee assignments · Source reportedCommittee assignments: Executive1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Cybersecurity experience · CorroboratedCybersecurity experience: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive company · CorroboratedExecutive at MIRA Pharmaceuticals, Inc.Supported by 2 public records2 sources
Verification
Corroborated
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive company · Source reportedExecutive at Telomir Pharmaceuticals, Inc.1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive title · Source reportedExecutive title: Chief Executive Officer1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive title · CorroboratedExecutive title: Chief Executive Officer and ChairmanSupported by 2 public records2 sources
Verification
Corroborated
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Other Company Role · Source reportedErez Aminov is also linked to Telomir Pharmaceuticals, Inc. as Chief Executive Officer.1 source
Verification
Source reported
Confidence
70%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Technology background · CorroboratedTechnology background: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

View all sources7 records
  1. https://www.sec.gov/Archives/edgar/data/1971532/000149315226035026/formdef14a.htm

    Sec Def 14a · Tier not stated · Reviewed Sep 13, 2026

    Supports: Chief Executive Officer and Chairman at Telomir Pharmaceuticals, Inc. (NASDAQ: TELO)

  2. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: Executive company · Executive title · Other Company Role

  3. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: AI and ML experience · Cybersecurity experience · Executive company · Executive title · Technology background

  4. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: AI and ML experience · Board role · Committee assignments · Executive company · Executive title · Cybersecurity experience · Technology background

  5. https://www.sec.gov/Archives/edgar/data/1904286/000149315224029259/formdef14a.htm

    Sec Proxy · Tier not stated · Reviewed Apr 29, 2026

    Supports: Director at MIRA PHARMACEUTICALS, INC. (NASDAQ: MIRA)

  6. https://www.sec.gov/Archives/edgar/data/1904286/000149315224029259/formdef14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership

  7. https://www.sec.gov/Archives/edgar/data/1971532/000149315226035026/formdef14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership